Tumor-to-kidney ratios for tissue uptake of [111In]DOTA-NAP-amide, [111In]DOTA-NAP-d-Asp-d-Asp, and [111In]DOTA-Phospho-MSH2-9 after 4, 24, and 48 h postinjection. This evidence concerns the gene MSH2 and neoplasm.